HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been prescribed HIV treatment medication (antiretroviral therapy)
- People who are willing to sign a consent form, which includes allowing the trial team to communicate with their primary HIV doctor
Who may not be able to join:
- People whose medical records show certain drug resistance that would reduce how well the HIV medications cabotegravir and rilpivirine work for them
- People who are taking certain medications that are not allowed in this trial
- People who are currently pregnant
- People who, in the opinion of the trial doctor, have mental health, cognitive, or behavioural conditions that would make it difficult to take part in the trial
- People who are seriously ill or hospitalised at the time of joining the trial
- People who plan to move away from the trial location within the next 12 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Allison Agwu, MD, SCM, Johns Hopkins University
Phone: 410-614-3917
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants who reach viral suppression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.